| 发明名称 |
6-arylalkylamino- 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2c receptor agonists |
| 摘要 |
The present invention provides 6-substituted 2,3,4,5-tetrahydro-lH- benzo[d]azepines of Formula (I) as selective 5-HT2c receptor agonists for the treatment of 5-HT2c associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety, where, R6 is -NR10R11, where R10 is substituted phenylalkyl or substituted pyridylalkyl and other substituents are as defined in the specification. |
| 申请公布号 |
AU2006287202(B2) |
申请公布日期 |
2013.01.24 |
| 申请号 |
AU20060287202 |
申请日期 |
2006.09.01 |
| 申请人 |
ELI LILLY AND COMPANY |
发明人 |
ADEVA BARTOLOME, MARTA;MARTINEZ-GRAU, MARIA ANGELES;REINHARD, MATTHEW ROBERT;O'TOOLE, JOHN CUNNINGHAM;CASES-THOMAS, MANUEL JAVIER;RATHMELL, RICHARD EDMUND;WILLIAMS, ANDREW CAERWYN;MAZANETZ, MICHAEL PHILIP;GALKA, CHRISTOPHER STANLEY;SAPMAZ, SELMA;BRINER, KARIN;MARCOS LLORENTE, ALICIA |
| 分类号 |
C07D223/16;A61K31/55;A61P3/00;C07D401/12;C07D403/12;C07D409/12;C07D413/12;C07D417/12 |
主分类号 |
C07D223/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
